. . . . "Kognitivn\u00ED efekt antidepresiv"@cs . . . . "Grada Publ." . . "[0A4C2E7B1BDB]" . "11120" . . "Auto\u0159i popisuj\u00ED kognitivn\u00ED efekt antidepresiv a jejich vliv na stav bd\u011Blosti a pam\u011Bti. Sertralin a milnacipram jsou nov\u011Bj\u0161\u00ED antidepresiva, u kter\u00FDch nebylo prok\u00E1z\u00E1no \u017E\u00E1dn\u00E9 negativn\u00ED ovlivn\u011Bn\u00ED kognitivn\u00EDch funkc\u00ED u zdrav\u00FDch jedinc\u016F. U depresivn\u00EDch pacient\u016F vedou n\u011Bkter\u00E1 antidepresiva (nap\u0159. dosulepin \u010Di trazodon) k tlumen\u00ED bd\u011Blosti. Viloxazin a maprotilin nemaj\u00ED negativn\u00ED efekt ani na bd\u011Blost, ani na vizu\u00E1ln\u00ED a verb\u00E1ln\u00ED pam\u011B\u0165. Sertralin zlep\u0161uje pozornost i verb\u00E1ln\u00ED u\u010Den\u00ED u depresivn\u00EDch nemocn\u00FDch nad 60 let signifikantn\u011B v\u00EDce ne\u017E nortriptylin. Venlafaxin a moclobemid zlep\u0161uj\u00ED bd\u011Blost u depresivn\u00EDch pacient\u016F. Moclobemid, fluoxetin, citalopram i trazodon zlep\u0161uj\u00ED pam\u011B\u0165ov\u00E9 funkce u depresivn\u00EDch nemocn\u00FDch. Ani dlouhodob\u00E9 u\u017E\u00EDv\u00E1n\u00ED tricyklick\u00FDch antidepresiv (medi\u00E1n 11,5 let), kter\u00E9 maj\u00ED nejvy\u0161\u0161\u00ED anticholinergn\u00ED ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky a dal by se u nich p\u0159edpokl\u00E1dat farmakogenn\u011B navozen\u00FD dementogenn\u00ED efekt, nevedlo k vy\u0161\u0161\u00EDmu poklesu v MMSE ve srovn\u00E1n\u00ED s probandy, kte\u0159\u00ED tricyklick\u00E1 antidepresiva neu\u017E\u00EDvali. Elektroko" . . . "RIV/00216208:11120/06:00000029!RIV10-MSM-11120___" . . "481881" . "Z(MSM0021620816)" . "Cognitive effect of antidepressants"@en . . "Auto\u0159i popisuj\u00ED kognitivn\u00ED efekt antidepresiv a jejich vliv na stav bd\u011Blosti a pam\u011Bti. Sertralin a milnacipram jsou nov\u011Bj\u0161\u00ED antidepresiva, u kter\u00FDch nebylo prok\u00E1z\u00E1no \u017E\u00E1dn\u00E9 negativn\u00ED ovlivn\u011Bn\u00ED kognitivn\u00EDch funkc\u00ED u zdrav\u00FDch jedinc\u016F. U depresivn\u00EDch pacient\u016F vedou n\u011Bkter\u00E1 antidepresiva (nap\u0159. dosulepin \u010Di trazodon) k tlumen\u00ED bd\u011Blosti. Viloxazin a maprotilin nemaj\u00ED negativn\u00ED efekt ani na bd\u011Blost, ani na vizu\u00E1ln\u00ED a verb\u00E1ln\u00ED pam\u011B\u0165. Sertralin zlep\u0161uje pozornost i verb\u00E1ln\u00ED u\u010Den\u00ED u depresivn\u00EDch nemocn\u00FDch nad 60 let signifikantn\u011B v\u00EDce ne\u017E nortriptylin. Venlafaxin a moclobemid zlep\u0161uj\u00ED bd\u011Blost u depresivn\u00EDch pacient\u016F. Moclobemid, fluoxetin, citalopram i trazodon zlep\u0161uj\u00ED pam\u011B\u0165ov\u00E9 funkce u depresivn\u00EDch nemocn\u00FDch. Ani dlouhodob\u00E9 u\u017E\u00EDv\u00E1n\u00ED tricyklick\u00FDch antidepresiv (medi\u00E1n 11,5 let), kter\u00E9 maj\u00ED nejvy\u0161\u0161\u00ED anticholinergn\u00ED ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky a dal by se u nich p\u0159edpokl\u00E1dat farmakogenn\u011B navozen\u00FD dementogenn\u00ED efekt, nevedlo k vy\u0161\u0161\u00EDmu poklesu v MMSE ve srovn\u00E1n\u00ED s probandy, kte\u0159\u00ED tricyklick\u00E1 antidepresiva neu\u017E\u00EDvali. Elektroko"@cs . "antidepressants; depressive disorder; cognition; vigility; memory"@en . "Praha" . "Kognitivn\u00ED efekt antidepresiv" . "The authors describe the cognitive effects of antidepressants and their influence on the state of alertness and memory. Sertraline and milnacipram are newer antidepressants that have not been shown to have a negative effect on cognitive function in healthy subjects. In depressive patients maintain certain antidepressants (eg trazodone or dosulepin) for the control of vigilance. Viloxazine and maprotiline have a negative effect either on alert or on the visual and verbal memory. Sertraline improves attention and verbal learning in depressive patients over 60 years, significantly more than nortriptyline. Venlafaxine and moclobemide improved vigilance in depressive patients. Moclobemide, fluoxetine, citalopram and trazodone improve memory function in depressive patients. And long-term use of tricyclic antidepressants (median 11.5 years), which have the highest anticholinergic side effects and could be assumed they farmakogenn\u011B induced dementogenn\u00ED effect did not result in a higher decline in MMSE compare"@en . "Kope\u010Dek, Miloslav" . "Kognitivn\u00ED efekt antidepresiv"@cs . . "416"^^ . "80-247-1460-4" . . "27"^^ . . "Kognitivn\u00ED efekt antidepresiv" . . "1"^^ . "Cognitive effect of antidepressants"@en . "1"^^ . "Neuropsychologie v psychiatrii" . "RIV/00216208:11120/06:00000029" .